Kyverna Therapeutics

Kyverna Therapeutics is a clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases. Their lead CAR T-cell therapy candidate, KYV-101, is advancing through clinical development with sponsored clinical trials across two broad areas of autoimmune disease: rheumatology and neurology. Kyverna's pipeline includes next-generation chimeric antigen receptor (CAR) T-cell therapies in both autologous and allogeneic formats, with properties intended to be well suited for use in B cell-driven autoimmune diseases.

Kyverna is committed to developing a safe and effective autologous anti-CD19 CAR-T cell therapy for the treatment of B-cell driven autoimmune diseases. Participation in clinical trials is the best way to access their investigational product candidate. Kyverna also considers requests for expanded access when alternative therapy options have been exhausted. The company emphasizes a patient-centric approach, working with world-renowned centers and physicians to deliver a safe, predictable, and transparent treatment experience.

Kyverna Therapeutics is a patient-centered company focused on developing cell therapies for autoimmune diseases. The company offers a variety of job opportunities with a collaborative and inclusive work environment, however, there is no information on their website about the flexibility provided to employees. NONE.

Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company dedicated to developing innovative cell therapies for patients suffering from autoimmune diseases. They aim to harness the power of CAR T-cell therapy to achieve sustained, treatment-free remission and alleviate the risks of long-term toxicities associated with traditional therapies. Kyverna's mission is to bring life-changing therapeutic benefits to patients with autoimmune diseases by resetting their immune systems and offering a potential paradigm shift in treatment.

Kyverna promotes a culture that is both intellectually rigorous and collaborative. They value thoughtful questioning, positive intent in all collaborations, and a commitment to integrity and empathy in their mission to fulfill a vast unmet patient need. This diverse team, comprised of individuals from various scientific, industry, and cultural backgrounds, fosters an open, supportive, and inclusive environment where employees can learn and grow both professionally and personally.

Kyverna Therapeutics embraces a diverse and inclusive culture, recognizing that a varied workforce is essential for developing groundbreaking therapies. Their commitment to equity ensures that everyone has equal opportunities to contribute their unique skills and perspectives. Kyverna actively seeks to attract, develop, and retain employees from diverse backgrounds, fostering a workplace where all feel valued, respected, and empowered to reach their full potential.